Fmoc-trans-4-fluoro-Pro-OH

Fmoc-trans-4-fluoro-Pro-OH is an Fmoc-protected trans-4-fluorinated proline amino acid bearing a stereodefined ring substituent at the 4-position of the pyrrolidine. The molecule combines an N-(9H-fluoren-9-ylmethoxycarbonyl) protecting group for orthogonal compatibility with standard peptide coupling and a carboxylic acid suitable for C-terminal activation. The trans relationship between the fluorine-bearing stereocenter and the proline ring framework constrains conformational preferences, while the C-F bond provides metabolic-stability-relevant electronic effects and a handle for downstream functionalization or SAR mapping. The fluorinated side-chain also influences reactivity and coupling behavior by modulating sterics and polarity around the amino acid backbone, making it a chiral, structure-defined intermediate for peptide and peptidomimetic construction.

1. Peptide Synthesis

Fmoc-trans-4-fluoro-Pro-OH supports solid-phase peptide synthesis and solution-phase peptide coupling workflows where Fmoc deprotection and subsequent amide bond formation are required. The Fmoc-protected proline nitrogen enables controlled N-terminal presentation, while the free carboxylic acid participates in standard activation chemistries to form peptide bonds at the C-terminus. The trans-4-fluoro stereochemistry and fluorinated side-chain contribute defined 3D geometry within peptide backbones, which can be leveraged to build conformationally biased sequences. Incorporation into peptide building blocks supports routine generation of fluorinated peptide analogs for medicinal chemistry and biochemical probe preparation, and the C-F motif can be retained for analytical detectability and structure-activity relationship studies.

2. Peptidomimetics And SAR Studies

Fmoc-trans-4-fluoro-Pro-OH serves in peptidomimetic design and structure-activity relationship investigations where proline-derived ring constraints and a fluorinated substituent are used to tune molecular recognition. The pyrrolidine core provides a rigid backbone element, and the trans-4-fluoro substitution can alter local electronics and hydrogen-bonding patterns without introducing additional heteroatoms. The Fmoc-protected amino acid format allows systematic incorporation into peptide-like scaffolds, enabling parallel synthesis of analog series with controlled stereochemistry at the fluorinated center. Downstream use can include preparing fluorine-bearing fragments for fragment-based molecular design, generating SAR panels, and supporting comparative studies of binding-site tolerance to halogen substitution.

3. Side-Chain Functionalization

Fmoc-trans-4-fluoro-Pro-OH can be applied to amino acid derivatization strategies that exploit the fluorinated side-chain as a stable stereodefined substituent or as a precursor for further chemical modification. The C-F bond can act as a persistent group for property modulation in final peptides, while the fluorinated stereocenter allows consistent placement of the substituent during peptide assembly. The Fmoc group provides a temporary protection handle that can be removed to expose the proline nitrogen for sequential coupling or for conversion into additional N-substituted derivatives. The resulting fluorinated intermediates can feed downstream synthetic routes toward labeled or functionalized proline-containing motifs used in chemical biology research and synthetic organic chemistry.

4. Chemical Biology Probes

Fmoc-trans-4-fluoro-Pro-OH is suitable for chemical biology workflows that require incorporation of fluorinated proline residues into peptide probes for mechanistic studies. The stereodefined proline unit supports conformational control in peptide recognition elements, while the fluorine substituent can influence stability and can provide a spectroscopically informative handle for NMR-based monitoring of analog integrity. The Fmoc-protected amino acid format enables predictable integration into probe sequences, including N-terminal or internal residue placement depending on the coupling order. The carboxylic acid functionality supports conversion into activated intermediates for peptide construction, enabling generation of fluorinated peptide tools for studying binding interactions, substrate preferences, or conformational effects in biomolecular systems.

5. Pharmaceutical Intermediate Preparation

Fmoc-trans-4-fluoro-Pro-OH is relevant to pharmaceutical intermediate preparation and fine chemical synthesis where fluorinated, stereodefined amino acid building blocks are required for manufacturing-oriented peptide analogs. The Fmoc protection strategy supports orthogonal handling during multi-step synthesis, allowing controlled deprotection and coupling sequences that align with scalable peptide manufacturing logic. The trans-4-fluoro stereochemistry provides a defined chiral motif that can be carried through to final active or intermediate peptide structures used in downstream drug-discovery pipelines. The resulting fluorinated proline-containing intermediates can also serve as process chemistry inputs for producing standardized lots of peptide fragments, enabling consistent assembly of fluorinated scaffolds for analytical method development and intermediate generation.

1. P-selectin and Complement’s Role in a Neonatal Model of Germinal Matrix Hemorrhage-Induced Secondary Injury

2. Sex differences in oxidative stress level and antioxidative enzymes expression and activity in obese pre-diabetic elderly rats treated with metformin or liraglutide

3. The spatiotemporal control of signalling and trafficking of the GLP-1R

4. High fat diet and GLP-1 drugs induce pancreatic injury in mice

5. Cationic cell-penetrating peptides are potent furin inhibitors